Kamada Ltd.

ILA 2,234As of Sun 8 Nov 2026, 12:00 UTC
TASE:KMDAHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR 0.81%
Div yield 3.36%
ROE 8.40%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.20
PE TTM 19.69
TSR TTM 3.12%
Mkt cap ILS 1.289B
ROIC 11.35%
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 2,379
6.48%
325.53%
Hold 2|4|12|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
55.12
53.08
51.52
52.06
8.73%
8.38%
(5.93%)
(10.11%)
Revenue$M
140.1
137.9
140.3
145.3
(4.54%)
(5.27%)
(2.91%)
3.15%
Peers (US$402.8M)
Cap (US$)
PE
38.71M
—
Capital
TTM
5Y
10Y
Leveragex
0.449
0.049
0.035
EBIT/Intx
2.600
1.833
1.837
Own earn%
148.28
148.35
137.03
Sh yield%
10.37
29.39
32.58
Owners
Insiders/Inst%
6.30
50.93
Short interest%
3.27
SBC / revenue%
4.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
26–34
$1 testx
—
Incr. ROIC%
23